Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00981968 · ClinicalTrials.gov registry record · Phase 1
Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT00981968 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 22 participants.
The verdict
NCT00981968, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate safety, tolerability and pharmacokinetics of sitaxentan following single and multiple oral administrations of sitaxentan sodium in Japanese healthy subjects.
Interventions
- DRUG Sitaxentan sodium/Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00981968
The ClinicalTrials.gov registry entry for NCT00981968 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sitaxentan sodium/Placebo is the first listed.
NCT00981968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00981968 about?
NCT00981968 is a clinical study titled "Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects". The purpose of this study is to investigate safety, tolerability and pharmacokinetics of sitaxentan following single and multiple oral administrations of sitaxentan sodium in Japanese healthy subjects.
What is the current status of trial NCT00981968?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2009-09. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00981968?
The interventions under investigation include: Sitaxentan sodium/Placebo (DRUG).
Who is sponsoring clinical trial NCT00981968?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.